Markov modelling of changes in HIV-specific cytotoxic T-lymphocyte responses with time in untreated HIV-1 infected patients

被引:16
|
作者
Kousignian, I
Autran, B
Chouquet, C
Calvez, V
Gomard, E
Katlama, C
Rivière, Y
Costagliola, D
机构
[1] Hop La Pitie Salpetriere, INSERM, EMI 0214, F-75625 Paris 13, France
[2] Hop La Pitie Salpetriere, INSERM, U543, F-75625 Paris, France
[3] Hop La Pitie Salpetriere, Virol Lab, F-75625 Paris 13, France
[4] Hop La Pitie Salpetriere, Serv Malad Infect & Trop, F-75625 Paris 13, France
[5] CHU Cochin Port Royal, INSERM, U445, Paris, France
[6] Inst Pasteur, Dept Sida & Retrovirus, Paris, France
[7] CNRS, UMR C5583, Lab Stat & Probabil, Toulouse, France
关键词
cytotoxic T-lymphocytes (CTL); Markov process; Bayesian inference; Monte Carlo Markov chains (MCMC); Gibbs sampling algorithm;
D O I
10.1002/sim.1404
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
HIV-specific cytotoxic CD8(+) T-lymphocytes (CTL) appear to be the cornerstone of the immune response to HIV infection. Recent studies show that CTL activity reflects patients' anti-HIV immune status and slows disease progression. However, the dynamics of the diversity of this response also appears as a key parameter for immune control but the dynamics of this diversity is largely undocumented. We modelled changes in CTL responses against the seven principal HIV proteins over time. We also studied the influence of plasma viral load on temporal changes in HIV protein recognition by memory CTL. The generic model we developed is based on a continuous time homogeneous Markov process with reversible states. Those states are defined by the number of proteins recognized by memory CTL in a given patient at a given time. This approach was developed within a Bayesian framework. Full Bayesian inference is implemented using Markov chain Monte Carlo simulations (MCMC). The Gibbs sampling algorithm was used to estimate the marginal posterior distributions of the transition intensities between stages of CTL responses. We applied our model to data of 152 HIV-infected patients included in the IMMUNOCO cohort. The model suggested that the diversity of HIV protein recognition by memory CTL in treatment-naive patients decreases as the disease progresses. Namely, the loss of T cytotoxic responses is globally faster than their acquisition. Indeed, these patients' T cytotoxic responses were characterized by marked individual turnover and a gradual loss of multiple protein recognition over time, this loss accelerating as viral load increased. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:1675 / 1690
页数:16
相关论文
共 50 条
  • [1] HIV-specific cytotoxic T-lymphocyte activity in immunologically normal HIV-infected persons
    Bernard, NF
    Pederson, K
    Chung, F
    Ouellet, L
    Wainberg, MA
    Tsoukas, CM
    [J]. AIDS, 1998, 12 (16) : 2125 - 2139
  • [2] VIRUS-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSES IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS, HIV-1
    RIVIERE, Y
    [J]. CELLULAR AND MOLECULAR BIOLOGY, 1994, 40 : 45 - 48
  • [3] Cytotoxic T-lymphocyte responses to HIV-1 reverse transcriptase (review)
    Menéndez-Arias, L
    Mas, A
    Domingo, E
    [J]. VIRAL IMMUNOLOGY, 1998, 11 (04) : 167 - 181
  • [4] THE CYTOTOXIC T-LYMPHOCYTE RESPONSE IN HIV-1 INFECTION
    KALAMS, SA
    WALKER, BD
    [J]. CLINICS IN LABORATORY MEDICINE, 1994, 14 (02) : 271 - 299
  • [5] No evidence for competition between cytotoxic T-lymphocyte responses in HIV-1 infection
    Fryer, Helen R.
    Scherer, Almut
    Oxenius, Annette
    Phillips, Rodney
    McLean, Angela R.
    [J]. PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2009, 276 (1677) : 4389 - 4397
  • [6] HIV-1 p24 Gag-specific cytotoxic T-lymphocyte responses in mice
    Doe, B
    Walker, CM
    [J]. AIDS, 1996, 10 (07) : 793 - 794
  • [7] Effect of zidovudine postexposure prophylaxis on the development of HIV-specific cytotoxic T-lymphocyte responses in HIV-exposed healthcare workers
    D'Amico, R
    Pinto, LA
    Meyer, P
    Landay, AL
    Harris, AA
    Clerici, M
    Berzofsky, JA
    Shearer, GM
    Kessler, HA
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (06): : 428 - 430
  • [8] HIV-specific T-lymphocyte proliferative responses induced by a multigene multiclade HIV-1 DNA/MVA heterologous vaccine in Tanzanian volunteers
    Aboud, S.
    Mhalu, F.
    Bakari, M.
    Lifson, J.
    Lyamuya, E.
    Marovich, M.
    Cox, J.
    Sandstrom, E.
    Biberfeld, G.
    Nilsson, C.
    [J]. RETROVIROLOGY, 2009, 6
  • [9] Early HIV-1 envelope-specific cytotoxic T lymphocyte responses in vertically infected infants
    Pikora, CA
    Sullivan, JL
    Panicali, D
    Luzuriaga, K
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (07): : 1153 - 1161
  • [10] CYTOTOXIC T-LYMPHOCYTE ACTIVITY IN CHILDREN INFECTED WITH HIV
    FROEBEL, KS
    ALDHOUS, MC
    MOK, JYQ
    HAYLEY, J
    ARNOTT, M
    PEUTHERER, JF
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S83 - S88